1. Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics
- Author
-
Katja Stefan, Jens Pahnke, Vigneshwaran Namasivayam, and Sven Marcel Stefan
- Subjects
ATP, Adenosine-triphosphate ,NBD, nucleotide binding domain ,GSH, reduced glutathione ,Polypharmacology ,Alzheimer’s disease (AD) ,ATP-binding cassette transporter ,HTS, high-throughput screening ,Biochemistry ,ABCA7 ,Structural Biology ,PLIF, protein ligand interaction ,MSD, membrane spanning domain ,PDB, protein data bank ,TM, transmembrane helix ,ABC, ATP-binding cassette ,Multitarget modulation (PANABC) ,RMSD, root mean square distance ,ABC transporter (ABCA1, ABCA4, ABCA7) ,Computer Science Applications ,MOE, Molecular Operating Environment ,Pharmacophore ,SNP, single-nucleotide polymorphism ,Biotechnology ,Research Article ,BBB, blood-brain barrier ,Biophysics ,Drug design ,Computational biology ,Biology ,AD, Alzheimer’s disease ,PET, positron emission tomography ,IC, intracellular helix ,APP, amyloid precursor protein ,cryo-EM, cryogenic-electron microscopy ,Genetics ,Homology modeling ,Binding site ,Rational drug design and development ,ComputingMethodologies_COMPUTERGRAPHICS ,NBD-cholesterol, 7-nitro-2-1,3-benzoxadiazol-4-yl-cholesterol ,Transporter ,PSO, particle swarm optimization ,PET tracer (PETABC) ,ECD, extracellular domain ,R-domain/region, regulatory domain/region ,ABCA1 ,biology.protein ,EH, extracellular helix ,TP248.13-248.65 ,BODIPY-cholesterol, 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-cholesterol - Abstract
Graphical abstract, The adenosine-triphosphate-(ATP)-binding cassette (ABC) transporter ABCA7 is a genetic risk factor for Alzheimer’s disease (AD). Defective ABCA7 promotes AD development and/or progression. Unfortunately, ABCA7 belongs to the group of ‘under-studied’ ABC transporters that cannot be addressed by small-molecules. However, such small-molecules would allow for the exploration of ABCA7 as pharmacological target for the development of new AD diagnostics and therapeutics. Pan-ABC transporter modulators inherit the potential to explore under-studied ABC transporters as novel pharmacological targets by potentially binding to the proposed ‘multitarget binding site’. Using the recently reported cryogenic-electron microscopy (cryo-EM) structures of ABCA1 and ABCA4, a homology model of ABCA7 has been generated. A set of novel, diverse, and potent pan-ABC transporter inhibitors has been docked to this ABCA7 homology model for the discovery of the multitarget binding site. Subsequently, application of pharmacophore modelling identified the essential pharmacophore features of these compounds that may support the rational drug design of innovative diagnostics and therapeutics against AD.
- Published
- 2021